Skip to main content

Table 3 Comparison of adverse pregnancy outcomes across the three groups based on ISSHP categories

From: Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study

 

C-1

C-2

C-3

C-1 vs. C-3

C-2 vs. C-3

C-1 vs. C-3

C-2 vs. C-3

(n = 42)

(n = 28)

(n = 34)

P value

P value

OR

95% CI

OR

95% CI

Acidosis

3(7.1%)

2(7.1%)

9 (26.5%)

<  0.05

<  0.05

4.68

1.15–18.98

4.68

0.92–23.83

Apgar score (5 min) < 7

2 (4.8%)

0 (0%)

6 (17.6%)

n.s.

4.29

0.81–22.80

Stillbirth

0

0

1 (2.9%)

Neonatal mortality

0

0

1 (2.9%)

Composite adverse pregnancy outcomes

5 (11.9%)

2 (7.1%)

12 (35.5%)

<  0.05

<  0.005

4.04

1.25–12.99

7.09

1.43–35.16

  1. Abbreviations: C-1, classification 1; C-2, classification 2; C-3, classification 3; OR, odds ratio; CI, confidence interval; n.s., not significant; ISSHP, International Society for the Study of Hypertension in Pregnancy
  2. Acidosis is defined as umbilical artery pH < 7.20. The composite adverse pregnancy outcomes include acidosis, Apgar score < 7 at 5 min, stillbirth, and neonatal mortality
  3. Data are presented as n (%), or OR with 95% CI
  4. P-values < 0.05 were considered statistically significant